Rachel L. Davis
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Immunotherapy and Immune Responses, Animal Virus Infections Studies, Acute Ischemic Stroke Management, CAR-T cell therapy research
Most-Cited Works
- → Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy(2019)293 cited
- → Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants(2021)213 cited
- → Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine–boosted nonhuman primates(2021)104 cited
- → Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates(2021)73 cited
- → Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates(2021)36 cited
- → Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones(2022)36 cited
- → Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman Primates(2021)10 cited
- → Surgical excision of iridociliary tumors using a postero‐anterior cyclo‐iridectomy and thermocautery in two dogs(2020)7 cited
- → Late Lesion Growth following Endovascular Therapy: Is 24 h Too Early to Assess Acute Infarct Size Including the Effects of Secondary Injury?(2024)7 cited